The Uromigos
A podcast by The Uromigos
401 Episodes
-
Episode 203: Renee Saliby in the Rising Star series
Published: 14/11/2022 -
Episode 202: The Uromigos Paper of the Month - Docetaxel with or without continuous enza in CRPC
Published: 7/11/2022 -
Episode 201: PARPi in CRPC
Published: 1/11/2022 -
Episode 200: Chromophobe renal cancer
Published: 25/10/2022 -
Episode 199: The Uromigos Paper of the Month - FGFR inhibition in bladder cancer
Published: 17/10/2022 -
Episode 198: The RADICALS trial in prostate cancer
Published: 7/10/2022 -
Episode 197: The Uromigos Nashville 2022
Published: 29/09/2022 -
Episode 196: The COSMIC-313 Trial cabo/ipi/nivo in 1st line renal cancer
Published: 14/09/2022 -
Episode 195 ESMO 2022: EV Pembrolizumab in 1st line bladder cancer
Published: 13/09/2022 -
Episode 194 ESMO 2022: Pegylated il-2 + nivolumab in renal cancer
Published: 12/09/2022 -
Episode 193 ESMO 2022: PRESTO - a phase III trial of androgen annihilation in biochemically relapsed prostate cancer
Published: 11/09/2022 -
Episode 192 ESMO 2022: Summary of ESMO Adjuvant RCC Trials
Published: 11/09/2022 -
Episode 191 ESMO 2022: PROSPER study of neoadjuvant nivolumab in RCC
Published: 10/09/2022 -
Episode 190: ESMO 2022 Preview
Published: 2/09/2022 -
Episode 189: The Uromigos Paper of the Month - Robotic vs open cystectomy
Published: 22/08/2022 -
Episode 188: The 1st Uromigos Live and Unplugged face-to-face meeting
Published: 15/08/2022 -
Episode 187: Cora Sternberg - The Uromigos Legends Series
Published: 15/08/2022 -
Episode 186: Bernard Escudier - The Uromigos Legends Series
Published: 10/08/2022 -
Episode 185: The Uromigos Paper of the Month - ctDNA in prostate cancer
Published: 1/08/2022 -
Episode 184: Active surveillance in prostate cancer and the seeds of doubt
Published: 26/07/2022
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
